Clinical Trials in Massachusetts

Showing 2381-2400 of 15,316 trials

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

NCT04580420

The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.

Primary Hyperoxaluria Type 1End Stage Renal Disease

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 participantsStarted Apr 2021

San Francisco, California, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +15 more locations

COMPLETEDNA26 miles

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

NCT03406208

The aims of this study are to compare the effect and durability of two stress and symptom management programs tailored for patients with neurofibromatosis on quality of life and psychosocial functioning.

NeurofibromatosesNeurofibromatosis 1Neurofibromatosis 2+1 more

Massachusetts General Hospital228 participantsStarted Oct 2017

Boston, Massachusetts, United States

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Find Trials by Condition in Massachusetts

Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

Kidney Blood Flow During Exercise in Older African American Adults

Ribociclib and Letrozole Treatment in Ovarian Cancer

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies